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Stimu latio n of g rowth and diffe rentiation of human epi-
dermis by epiderma l g rowth factor (EGF) is med iated by 
its binding to speciftc receptors. Whether EGF receptors 
primaril y mediate cell divi sion or differentiation in hyper-
pro liferative disease such as psoriasis vu lga ri s is unclear. 
To study the pathogenesis of psoriasis , 4-mm 2 pun ch bi-
opsy specim ens of nonna l, uninvolved , and in volved pso-
riatic sk in were assayed for EGF receptors by autoradio-
gra phi c, immuno histochemi ca l, and biochemica l methods. 
Usin g autoradiographic and immunohi stochemi ca l meth-
ods, basa l keratinocytes were found to contain the g rea test 
number of EGF bindin g sites and immunoreactive recep-
tors as compared to the upper layers of the ep idermis in 
both no rm al ep idermis and pso ri atic skin. No EGF receptor 
differences between no rm al and pso riati c ep idermis were 
I n nor m al human epidermis, ep idermal g rowth fac to r (.EGF) receptors, as detected by autoradiography following f115Il EGF bindin g or by immuno histochemist ry utili zin g anti - EGF n:-ccptor antibody , we re loca ted primari ly o n the mito ti ca ll y active basal kerati nocytes and diminished in number as the 
cells became more differentiated 11 -41. A simil ar distribution of 
.EGF binding sites wa s found in vitro [5], indicating that this 
d istr ibutio n is not contro lled b y the dermi s. To study the ro le of 
EGF receptors in differentiation, we selected a benign human skin 
disease, psoriasis vulgaris, because the affected keratinocy tes may 
ha ve both an ab no rm all y increased proliferative capacity and an 
abnorm all y differentiated state. In active pso riati c sk in lesions, as 
in normal sk in, th e active ly dividin g keratin ocytes arc limited to 
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Abbreviations: 
BSA: bovine serum albumin 
EGF: epidermal growth fac tor 
1-1 J3SS: Hanks' ba!Jnced salt solmion 
1-1 EI'ES: 4- (2-h ydroxyeth yl)-1-piperazine-ethanes ulfonic acid 
1-ll tP: horseradis h peroxidase 
PBS: phosphate-buffered sa line 
PDGF: platelet-deri ved growth fac tor 
observed in this layer. In the upper laye rs of the epidermis, 
a 2- fo ld increase in EGF binding ca pacity was observed in 
psoriati c sk in as co mpared with normal thin or thick skin. 
Biochemical methods indicated that [125 l]EGF binding was 
in creased in psoriatic epidermis as compa red with similar 
thickness normal epidermis w hen measured on a protein 
basis. Epidermal growth fa cto r was shown to increase 
phosphorylation of the EGF receptor in skin. EGF recep-
tors retained in the non mitotic stratum spinosum and para-
keratotic stratum corneum m ay refl ect the inco mplete, 
abnormal differentiation that occurs in active psoriatic le-
sions. Alternatively, reta ined EGF receptors may play a 
direct role in inhibitin g cellular differentiation in the su-
prabasa l la yers. J Irwcst Dermatol 86:260-265, 1986 
th e first 2- 3 cell rows in the s tratum basalis 16-9], the epidermal 
cell b ye r closest to the basal lamina. lf.EGF receptors were simpl y 
a marker of mitotica ll y active cells, then the mito ti ca ll y active 
basa l cell layer in ac tive pso riati c lesion s shou ld be the major site 
of in creased numbers of EGF receptors. Conversely, if EGF re-
ceptors va ried as a fun ct ion of epiderm al differentiati o n, an in-
creased number of EGF recepto rs sho u ld be noted throughout 
th e abnorma ll y differenti atin g psoriatic epidermis . Previous stud-
ies had shown that large numbers of EGF receptors were present 
on cells in hum an skin that are m etaboli ca ll y very active but 
mitotica ll y ina ctive such as sweat du ct epithelium [2]. Ep idermal 
g rowth factor receptors arc also found o n mitoti ca ll y in ac ti ve 
arrector pili muscle and sm ooth muscle sites thro ug hout the body 
11 0]. Therefore, the co rrel ation of .EG F recepto rs with rapid cel-
lular proliferation is imperfect [11j. The present studies indicate 
that a consistent in crease in the number of.EGF receptors is present 
in psoriati c les io ns. However, the in creased number of EGF re-
cepto rs in active lesions was due to a persistence ofEGF recep tors 
primarily in sites o f abno rmal differentiation and not cellular di-
v isio n. T herefo re, abnorma l EGF receptor m etabolism m ay pla y 
a role in th e pathogenesis of the beni g n human h y perproliferative 
sk in disease , psoriasis vul garis . 
MATERIALS AND METHODS 
Reagents Epiderma l g rowth factor was purchased from Col-
laborative Research (Wa ltham , Massa chusetts), and [125-1]- and 
[32P]ATP were obtained from N ew Engbnd Nuclear (Boston, 
Ma ssachusetts). NTB-2 autoradiography emulsio n was obtained 
from Eastman K oda k (Rochester, New York). Goat antirabbit 
lgG conju gated to horseradish peroxidase (HRP) was purchased 
from Miles Laboratories (E lk hart, Indi ana) . T he supply of 3,3-
diami nobenzidine and bovine serum albumin (BSA) was from 
Sigma Chemica l Co . (St. Louis, Mi ssouri) . Calf serum , Dulbec-
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co's modifi ed Eagle 's medium , and H anks' balanced sa lt solution 
(HBSS) were purchased fro m GIBC O (Grand Island, New York) . 
All other reagents were purchased fro m common suppliers and 
we J:e of reagent grade. ' 
Acquisition of Tissues No rm al skin specimens from sites of 
thi ck p almar skin and thin breas t skin were collected from pati ents 
und e r go ing electi ve plas tic surgery at Vanderbilt or Veterans 
Administrati on M edi ca l Center it1 N ash ville, T ennessee. Punch 
bio p s i es were obtained using 1% hd ocaine anesth c;sia from 12 
pa tie nts w ith pso rias is vul ga ris from in vol ved and uninvolved 
skin b efore starting UV radiation and topical therapy with cor-
ticoste ro ids and /o r tar. 
Localization of [1251]EGF Binding by Autoradiogra-
phy Epiderm al g rowth facto r w as labeled with 125! by the chlo r-
amine -T m ethod, as previOusly descnbed (12) , to a specific ac-
tivity o f1.5 X 1 0~ cpm/ ,u.g . The [125 l]EGF bound to A-431 cell s 
and fibr o blas ts in a concentrati on-dependent, saturable, and re-
ver s ible manner (1 3, 14) . Excess unlabeled (2 ,u.g) EGF was added 
afte r ( 125 I)EGF binding to show th e ex tent of nonspecifi c o r non-
dis placea blc [125 l]EGF. 
Locali za tion of (125 l) EGF binding sites by auto radiog raph y in 
sec ti o ns of human skin was perfo rmed as previously described 
(1, 2) .- In brief, skin sa mples w ere sli ced into very small pieces (1 
1111112). Samples were incubated fo r 90 min at 25°C w ith shakin g 
in a m edium consis ting of 0. 5 ml HE SS containing 1 mg/ml 
BS A , 20 mM 4-(2-h ydroxyeth yl)-1-piperazineeth anesulfonic acid 
(HEP E S) pH 7.4 (binding buffer), and 10 ng/ml (125 1] EG F. Un-
bound EGF was removed by repeated was hes in the binding 
buffe £' a t 25°C. All skin sa mples were fi xed fo r 4 h in 10% neutral 
bu ffe r ed fo rmalin and processed fo r li ght m icroscopy in paraffin . 
Sectio n s (6 ,u.m) were dipped in a I: I mixture ofNTB-2 emulsion 
and di s tilled wa ter. Following ex pos ure at 4°C for 4-1 2 weeks. 
the e mulsion was developed fo r 2 min in Kodak D-19 de veloper 
at 10°C. Secti ons were stained w ith hematoxy lin and eosin and 
mounted in Perm ount. Photographs were m ade using an O lym-
pus PM-1 0-M mi crosco pe w ith bo th bright-fi eld an d dark-fi eld 
illuminati on . 
EGF Receptor Antiserum-Production and Charac-
terization The affinity-purified EG F receptor preparation, used 
to immunize rabbits to produ ce a specifi c an tise rum to the re-
ceptor, w as prepared as previ ously described (15 , 16]. Briefl y, the 
EGF r ecepto rs from A-43'1 human epithelioid ca rcinoma mem-
bra n e ves icles were solubilized at1d placed on an EG F affinit y 
column . The receptor was eluted with 5 mM ethano lamin e, pH 
9. 7, containing 10% glycerol and 0.2% Triton X-100 and th en 
electro phoresed by the meth od of Laemmli (17) . The Copmassie 
Blue- s tained receptor band was then cut out and appro)(imately 
S p.,g receptor pro tein inj ected into the rabbit in complete Freund 's 
adjuvant. One week later, antiserum collection was begun . The 
IgG f r action of th e anti seru m was pur ified by ammonium sul fa te 
precipitation (l i? ]. T he annserum (no . 163) cross- reac ted anc;l Im-
mun o precipitated nati ve EGF receptors from a number o f normal 
tissu es including no rmal human skin (1 ,2] and placenta (1 9]. The 
an tiser a also cross-reacted w ith precurso r and intracellular deg-
rada ti o n fo rms o f the EG F receptor (1 5, 16]. 
Localization of Immunoreactive EGF Receptor Mole-
cules C ryos tat-sectioned tissue sections (4-6 ,u.m) were fi xed in 
2.5°/~ g lutara ldehyde in phos phate-buffered saline (PBS) , pH 7.4, 
for 15 min at 25°C. The sections were rinsed and then incubated 
15 m in with 3% goat serum and lmg/ml g lycine in PBS. Sections 
were treated fo r 4 h at 25°C w ith either purifi ed no rmal rabbit 
!gG o r anti-EGF recepto r lgG diluted to· 0.05 mg/ml in goa t 
serum/glycine/PBS . After ex tensive washing; the secti ons were 
incu b a ted for 1 h w ith goa t antirabbit IgG conjuga ted to HRP 
diluted to 1 : 100 in goa t serum /glycine/ PBS. After rinsing , tissue 
sectio n s were reacted w ith 0.05% diamin obenzidine and 0.01% 
H20 2 in 0.05 Tris buffer at pH 7.6.· 
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[I 251]EGF Binding Assay The epidermis was separated from 
the dermis by incubation of 4-mm2 punch biopsies in 1 M N aBr 
fo r 1 h at 37°C. The epidermis vvas washed once w ith PBS and 
th en cut in to 16 pieces . Each piece of epidermis from no rmal 
thi ck or in volved and unin volved psoriatic skin w as additi onall y 
sliced ho rizo ntall y so that th e thicknesses of the pieces were sim-
il ar. This tissue size (0.25 mm 2) was chosen because smaller sa m-
ples we re too diffi cult to handle and larger sa mples bound less 
EGF at ea rly times, pres um.a bl y due to a slowed penetrati on of 
the li ga nds through the bigger sa mples (data no t shown). A single 
pi ece o f 0.25 mm 2 was used per assay w ith an interassay variation 
of approximately ± 10%. U sin g this sa mple size, it was then 
poss ible to meas ure to tal EG F binding, notis pecifi c binding, and 
to perform morpholog ic studies from a single biopsy. The bind-
ing mi xture in a to tal volume of 0.1 ml contained 50 ng/ ml 
of [l 25 l] EG F in binding buffer at 25°C fo r the indi ca ted times . 
N onspecifi c binding was defin ed as [1251J EG F bound in th e pres-
ence of a 1 00-fold excess of unlabeled EGF and generall y ranged 
between 35-45% of the to tal counts bound by the 0.25-mm2 
sa mpl es under optimal conditions. To terminate the binding re-
acti on, the med ium was removed by aspiration and the sa mples 
washed once in ice-co ld binding bu ffer and then washed twice 
with bind ing bu ffer without BSA . Sa mples were transferred to 
.1 2 x 75-mm tubes, so! .. D:Iized in 0. 1 ml 1 M N aO H fo r 1 h at 
37°C, and radioacti vity m eas ured in a -y-specrro meter. The pro-
tein content of each epiderm al sa mple was determined by the 
meth od of Lowry et al (20). 
EGF-Stimulated Phosphorylation Assay Frozen human 
mammary epidermis was scraped o ff the de rmis and immedi atel y 
placed in ice-cold PBS. The broken epidermis was pelleted by 
centrifu ga tion at 8,000 g for 5 min . It was then homogenized in 
a 10 x volume eth ylene glyco l bis(/3-amin oethyl ether)N , N , N ,N 
tetraacetic acid , 3 mM iodoaceti c acid in 20 mM HEPES buffer, 
pH 7. 4, usin g a g round-g lass ho mogenizer·. Nuclei and . unbroken 
cells were precipitated by centrifu ga tion at 600 g spin . The mem-
brane fraction of the supern atants was precipitated by centrifu-
gation at 100,000g fo r 1 h. The pellet was res uspended in 20 mM 
H EPES buffer, pH 7.4. A-431 cell m onola yers grown as prev i-
ously described (13) were washed 3 times w ith PBS, scraped, and 
homogenized in the homogeniza tion buffer. T he membrane frac-
ti on of th e supern atant was precipitated and suspended as de-
scribed above. 
The phosphorylation assay mi xture contained 75 J,t g epidermal 
membranes or 15 ,u.g A-431 membra nes, 0.1 % T ri ton X-100, 2 
m M MnC I2 , 10 J.t M va nadate, 0.25 mg/ ml BSA , 1 ,u.C i [-y-32) AT P 
(5 C i/,u.mol) (! C N , Irvine, Califo rnia) in 20 mM HEPES, pH 7.4, 
in the absence o r presence of 10 ng/ ,u.l EGF in a total volume of 
60 ,u.l. T he reaction proceeded fo r 10 min at ooc and was stopped 
by the addition of60 ,u.l o f 2 X Laemmli sa mple buffer (1 7]. After 
heatin g the sa mples to 95°C fo r 5 min , they were pl aced on a 6% 
polyacrylamide gel, electrophoresed , and the dried gel placed 
against a sheet o f Kodak X -0 O mat AR film . The film was 
exposed at 70°C w ith a Dupont Lightening Plus screen fo r one 
day. 
Protein and DNA Assays Protein content was determined by 
the method of Lowry et al [20] using BSA as a standa rd. O pti ca l 
densities were read at 500 nm on a Gilfo rd 2600 spectropho to-
meter. Additional sa mples were used to make determin ati ons o f 
D NA by the method of Erw in et al (21] . Fo r D N A analysis, a 
4-mm2 pun ch biopsy was incubated in 0. 5 ml N aBr (Fisher, 
Springfield , N ew j ersey) fo r l h at 37°C. Following a rinse w ith 
PBS, th e epidermis was peeled away and solubilized fo r 1 h at 
37°C in 0. 1 ml of N aO H . T o the solubilized epiderm is or 100-
,u.l aliquots o f ca lf thymus D NA (Worthington, N ew Jersey) , 0.5 
ml of trichlo roaceti c acid was added and the mi xture hea ted at 
90°C for 30 min . Supernatants were cooled to 4°C and mi crofu ged 
fo r 5 i11in ._ Supernatants were incubated at 60°C fo r 1 h with 100 
,u.l o r 200 mg/ ml 3,5-diaminobenzoic acid HCl (Aldrich, Mil-
waukee, Wisconsin). The reaction was stopped by the addition 
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of2 ml ofl N H C I. The fluorescen ce was m eas ured at ~ n excitat io n 
of 400 and an emissio n of 520 nm o n a Turner fluoro m eter. 
RES ULTS 
Autoradiography of [1251-EGF] Binding Sites 
Actil1c Psoriatic Lcsiom: We have prev iously shown that [ 1 ~5 l]EGF 
binding s ites in nor m al hum an skin were found primaril y in the 
b asa l and suprabasa l keratinocytcs I I .2 1. Thi s EGF bindin g was 
specifi c, sa tu_rablc , and revers ib le. The number o f EGF receptors 
as m easured b y an ultrast ru ctural m etho d w ith an anti-EGF re-
ce pto r antibody in th e sa m e skin samples co rre lated well with 
previously reported [125 l]EGF bindin g s ites 11 ,2 J and the quan-
titative autoradiog raph y (Table !). 
When bio psies from psoriatic lesions were in cubated in J125!JEGF, 
a marked in crease and a lteration in distribution of specifi c labelin g 
was o bserved (Fig IC, D , Table 1). In creased [ 1 ~5 IJ EGF bindin g 
was due to the in creased presence of bindin g sites in the upper 
strata of th e epidermis as well as a substantial in crease in epidermal 
thickness in p so riati c skin (Fig 1 C, D) as co mpared w ith unin-
volved adj acen t epidermis from the sa m e patient (Fig 1 A, B) and 
no rm al skin (data not show n) J1 ,2]. T he in volved pso ri ati c ep i-
dermis was more cellu la r (Fig 1 C, D) than '' unin volved" epider-
mis (Fig 1A,B). The number of sil ver g rains (representing JL5 I]EGF 
binding) in psoriati c epid ermis was also hi g hest over those a reas 
th at contained the greatest density of nucle i (Fig I D). Nuclei were 
present in the uppe r psoriatic epidermis in parakera totic fo ci, and 
[ 125 1J EGF binding activity was heavier in these areas . In reg io ns 
where no rm all y differentiatin g corn cocy tes (with o ut nu cle i) we re 
present, no s il ver g rain s w e re present (da ta not show n). 
M orphometri c analys is o f silver g rains was condu cted o n pso-
riatic les ion s. A !thou g h th e lower epidermal co mpartment (de-
fin ed as the first 3 basa l cell layers of bo th pso ri atic and norm al 
skin ) had a simi lar ca pa city to bind EGF. the uppe r co mpartm ents 
did no t have the sa me EG F bindin g ca pacity (Ta ble I}. Approx-
imatel y twi ce as 1iu n y g rain s were detec ted in the upper co m-
partments of psoriati c skin ::ts were found in no rm al skin (Tab le 
!) . In conclusio n, EGF bindin g in active psori atic les io ns is unu su al 
in that the binding sites we re not primari ly loca lized to the s tratum 
basa lis as was EGF bindin g in n o rmal skin [1, 2 J. 
An apparentl y p aradox ic resu lt is observed w hen the g rains per 
square micrometer arc co mpared between pso riatic and thin ep-
idermis . T hi s is a so m ewh at invalid co mparison s in ce the basa l 
la yer (w hi ch binds ve ry hi g h level s of EGF) in thin skin represents 
pro po rti o nate ly a hi g her es timated percenta ge o f th e epidermis 
than in psoriati c sk in (53'Yo vs 25%, respecti ve ly; Table II ) . Thus, 
pso ri atic skin must be compared w ith skin of s imi lar thi ckness 
in this respect. 
U11iii i!O i11Cd Psoriatic Sk i11 : In 3 o f the 12 patients, the skin adja cent 
to the active psoriati c les io ns was clini cally no rm al. H owever, by 
histologic exa mination , a sli ght in crease in epiderma l thickness 
was no ted (Fig 1 A,B). The pattern of J 1 ~5 !lEGF bindin g was in-
termediate be tween that of n o rm::t l skin and apparently no rmal 
unin vo lved skin taken from a distant s ite from a pso riat ic patient. 
Therefore , the intensity of[ 1251jEGF binding in " unin volved " skin 
va ried from levels tha t ap proached those seen in the active les io ns, 
Table I. Q u antitati ve M orpho metri c An alys is o f J125I JEG F 
Binding in N ormal Thin, Thick, and Pso riati c Epidermis'' 
Thick Thin Psoriatic 
Upper compartment 2.9 4. 1 ± 0.8 8.8 ± 0.7 
Lower compartment 15.5 14.7 ± 2.8 16.5 ± 1.7 
Total epiderm al 18. 8 20.5 18.95 
compa rtment 
11 = 3 n = 15 n = 8 
"Bindin g studies were performed :1 s in Mm crials rmd !vfethod.L Valu es represent the 
mea n :t SE (or specific-sil ve r grain s/p.m :!. 
T il E JOUHNAL OF INVESTIGATI VE DEI<M t\TOLOGY 
Figure 1. Autoradiographs of I' 2511EC F binding in human epidermis. 
Punch biopsy specim ens from . aclja cent unin vo lved (A ,JJ) or in vok ed 
(C, D) skin of a psoriatic patient were incubated with 1 ' ~5 11 EGF. sect ioned, 
and processed for autoradiograph y. Th e emu lsion was cxposl·d for 10 
weeks, the sect ion stained with hematoxylin and eos in, and vie wed by 
li ght- and dark-fi eld microscopy as described in t\lclfcrials ""'' Mctlt ods. In 
dark-l'ldd mi croscopy the silver g r:~in s represent in g I ' ~" I IEGF binding 
sites arc white (A ,C). whereas the sil ve r g rains in bri ght- field arc bbck 
(B, D). In in vo lved epidermis the sil ver g rai ns arc seen throughout th~ 
epidermis (C) , whcrl'<lS in the unin volved epide rmis (A) the sil vn grains 
arc heavi ly concc ntr:~ ted over the stratum basalis (h) and th e lower stratu m 
spin osum (s). T he dermis (d) and skin s urf:~ cc (./) arc visible. S i;:c ht~rs 
= 100 f.Lm . 
i. e . , pc ril es io nal skin , to leve ls w hi ch were the sa m e as th ose 
obse rved in skin sa mples taken from no rm al and no npso r ia ti c 
patients Jl ,2 J. 
Biochemical Characterization ofEGF Binding Human ep-
idermis was readi ly separated fro m the der mis b y in cubating the 
4-mm~ pun ch biopsies fro m n o rm al thi ck and thin skin in I M 
NaBr a t 37°C fo r I h. Excellent sep arati o n of th e psoria ti c epi-
dermis fro m the dermis was also possible des pite the aca nthotic 
and papi llo ma to us nature o f m an y specim ens (Fig 2). Under the 
sa m e conditi o ns, I M NaBr h ad n o detec tab le effec t o n J125 1J EGF 
binding to A-431 ce lls o r iso lated human keratin ocy te membranes 
(data no t show n) . In ag ree m ent w ith the morphologic data (line 
3, Tab le I) J 1 ~5 1 j EGF bindin g capacit y was hig hest in n o rm al thin 
skin, interm ediate in pso riati c skin, and lowest in no rm al thick 
skin w hen ca lcu lated o n a milli g ram protein ba sis (Fi g 3). Thu . 
the g rea ter the percentage o f th e basal b ycr to w ho le epidermis. 
the g rea ter the capa cit y of the w ho le epidermi s to bind EGF. 
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Figure 2. NaBr induced separation of psori atic epidermis ti·o m dermis. 
Prior to I125 1I EGF bindin g studies, sa mples o f intact norm al (not shown) 
o r pso ri ati c skin were in cubated in I M Na l3 r fo r I h :tt .17°C. T he epidermis 
(A) was peeled from 1hc der mis ( /3), prov iding :1 clca n separation of these 
skin co m pa rtmmts. T he cpidcrrnis retained specific EG F bindi ng sites as 
described in the te xt. H&·E. S i.:::c ht1r.< = 200 !J-In . 
Separating the va ri ous cell layers fro m no rm al and pso ri a ti c skin 
to quantify th e I1251J EG F binding per indi vidual la ye r was tech-
ni ca ll y unsatisfacto ry beca use thi s se paratio n required pro lo nged 
exposure to pro tea ses such as trypsin that affec ted the EGF bind-
ing (da ta no t shown). 
N o rm ali za ti o n of the I 1251 JEGF binding per un it of DNA In-
dicated that active pso ri at ic lesio ns m ay actually ha ve a d ecreased 
EGF binding ca pa city (T able II ) . These data a1-.: misleadin g si nce 
the proportion o f nu cleated o r DNA- containin g ce ll s differs 
marked ly in thin , thi ck . and pso ri atic epidermi s: Sin ce basa l kcr-
atinocytes ha ve th e g rea test ca pacity to bind EG F (T able I) I 1 .2 1. 
the e p ide rm al layers that have th e g reatest propo rti o n o f their 
nucleated ce ll s as basal ke ratin ocy tes sho uld have the g reates t EG F 
b inding ca pacit y per unit of DNA , i.e., no rmal thin epidermis . 
T hi s relatio ns hi p am o ng basa l kcratin ocy tes. nucl e:ned ce ll pop-
u la ti o ns, and tota l EGF bindin g per unit of DNA is indeed o b-
served (T able II ). 
EGF-Stimulated Phosphorylation in Normal Human 
Epidermis To determine w heth er the EGF recepto r in no rmal 
human skin has EGF-stimul atablc autoph osp ho ryla tin g acti v ity 
s irnil a r to th at obse rved in o th er t issues, a phos phory lat io n assay 
was perfo rm ed using epide rm al m embranes and A-43 1 ce lls. The 
phosp ho rylated m cm branes were so lubilized , pl aced o n a po ly-
acr y la mide ge l. and electro phoresed (Fig 4). As o bse rved in other 
tissu es /22,23 ), the m ajor ph os ph o rylated band w hi ch wa s s tim-
u la ted b y EGF had a m o lecul ar weig ht o f 170,000 . A-43 1 m em-
b ra n es, phospho rylated und er the same conditi o ns, were in cluded 
in thi s experim ent to show that th e ph os ph o rybred band in no r-
ma l human skin had th e sa m e elec trophoreti c m o bility as the well-
studied EG F receptor of 170,000 da lto ns in the A-43 1 cells [23-25 1. 
A trace of partiall y deg rad ed EGF receptor (M,. = 150,000) is also 
vis ible. Und er the co nditio ns used . EGF did no t affect the ph os-
pho rylation of o th er m embran e protein s in the extracts of no rm al 
huma n skin (Fig 4). 
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Figure 3. Tim e course of 1 ' ~5 1 )EGF binding to sep"rarcd epidermis from 
active psoriati c les ions as compared with normal thick and thin skin . 
Epidermis was separated by NaB r as described in Fig 2, incubated with 
1 ' ~5 1I EGF in binding buffe r fo r 1-24 h at 25°C, washed and quantitated 
as desc ri bed in i\1/arrria/s m1d Mc rhods. Under the conditions used, the peak 
binding acti vity of I "'-' II EGF in all samples occurred at approximatel y 
6 h. 
Immunoreactive EGF Receptors T he loca lization of im-
mun oreacti ve EGF recepto rs in acti ve and resolving psoriatic le-
sions is shown in Fig SA, C. In ti ssue section s from active psoriati c 
les io ns (Fi g SA) , a dense immuno precipitate was noted throug h-
Skin A431 
EGF + + 
Figure 4. Autoradiograph y o ( EGF-sti mulatcd phosphorylation of hu-
man epidermal and A-431 membranes. Membranes from normal hum an 
epidermis and neoplasti c A-43 1 ce ll s were prepared, phos phorylated with 
ly-32PIATP in the presence or absence of EGF, and prepared for auto-
radiograph y as descri bed in Mntl'l'ials a11d Merh ods. Under the conditions 
used. the EG F receptor migrates as a 170,000-da lton band whose phos-
phorylation is stimulated by EG F ( + ). 
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out all epiderm al layers. In no rmal epidermis , the immuno pre-
cipitate is found o nl y in the stratum basa lis and st ratum spinosum 
and is absent in corneocy tes (Fig SD) . In contrast, w hen preim-
mune lgG was used in place of the specifi c anti-EGF receptor 
antisera , no specific sta inin g was observed (Fi g SB). The im-
munoreactive EGF rece pto rs as loca lized by th e immuno perox-
id ase method had th e sa m e qualitative distributi on as th e E G F 
recepto rs localized by auto radi ograp hy of [125 I] EG F binding sites. 
Thus, EGF recep tors ap pea r to be reta ined througho~t the en tire 
thickness of psoriatic epidermis. In contrast, immunoreactive EGF 
recepto rs arc absent in the stratum co rn eu m in reg ress in g pso ri ati c 
les io ns (und ergo in g success ful treatment) (Fig SC) . H owever, 
receptors were still present in the st ratum basa lis, sp in os um , and 
gra nul osum . T his decrease o f EGF receptor density in the more 
di ffe rentiated upper epiderm al strata m o re close ly resembles the 
pattern of immunoreactive EGF recepto rs that is present in no rm al 
hum an epiden11 is of compa rab le thickness (Fig 51 ). 
D ISCUSS IO N 
The present stud y ind icated th at the distribution o f f 125I]EGF 
binding and immuno reacti ve EGF recepto rs was altered in ac tiv'e 
lesions of psoriasis vul gari s in that twice as m an y EGF receptors 
were presen t in the upperm ost layers of sk in w hen co mpared 
w ith normal skin . The distribution of EGF recepto rs in regressin g 
psoriatic les io ns· appea rs to be simil ar to that of act ive psoriatic 
les io ns, with the exceptio n of the stratum corn eum , w here both 
EGF recepto rs and nu clei have begun to d isa ppea r. In th e im-
mun ohistochemical stud ies , the anti-EGF receptor antibody used 
recogn izes bo th occupied and unoccupied EG F receptors, pre-
cursor forms of th e EGF recepto r, an d degraded forms of the 
EGF receptor [1 5, 16 [. Therefo re, th ese 2 m ethods were useful to 
determine the va li d ity of the EGF recepto r loca li za tio n, as each 
method studi ed different aspects of the EGF recepto r-under dif-
ferent co nditions bu t in the sa me sam ples. Biochemical mea-
surem ent of the EGF binding also showed that there was an 
increase in EGF receptors in psoriatic skin as compared w ith 
Figure 5. 1mmunoperoxidase staining of EG F receptors in normal and 
psoria ti c epidermis. Punch biopsy specimens from in volved psoriatic le-
sions (A ,B) , treated psoriatic les ions from the sa me patient (C), and nor-
mal thick palmar skin (D) were sectioned, washed , in cubated with norm al 
IgG (B) or with specific anti-EGF receptor IgG sera (A,C,D). and pro-
cessed for immunoperox idase sta ining as previously described 121 and in 
Mlllcrials and Methods. In active psoriatic lesions (A) , immunoreactive EGF 
recepto rs were present in all epidermal layers, whereas no specifi c staining 
was seen in the preimmune control sections (B). When the lesion began 
to regress while the patient was receiving UV therapy, immunoreactive 
EGF receptors were markedly reduced in the stratum corneum (C). In 
comparably thick norm al human skin , immunoreactive EGF receptors 
were primarily present in the stra tum basalis and nea rly absent from the 
stratum granu\osum and stratum corneum . S iz e l;ars = 100 Ji-m. 
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normal skin o f comparable thickness . Persisten ce of [125 I]EGF 
binding and immunoreactive EGF recepto rs in the active lesio n s 
o f psori as is v ul ga ris suggests that EGF m ay have a rol e in epi-
dermal ho m eostas is. The decrease o r return toward no nnallevels 
and distributi on of EGF recepto rs in regressin g lesions of pso ri as is 
vul ga ris could have impo rtant impli cations in the clini cal nu n-
age m ent of this disease. 
In o ur prev ious studies on no rmal human epidermis [1 ,2] , 
f 125 !JEGF binding o r immuno reactive EGF receptors primaril y 
occurred in the first 2 o r 3 layers of basal and suprabasal keratin-
ocytcs . In the present stud y, th e level of EGF recepto rs de tected 
in th e ac ti ve les ions of ps <:.> riasis was also highes t in the lo wer 
co mpartm en t and did no t signifi ca ntl y di ffer in number of EGF 
recepto rs. T hu s, ou r data do no t support th e hy po thesis that an 
in crease in EG F receptors should occu r onl y on th e mitoti cally 
ac tive ce lls in psorias is. These data are in acco rd with previous 
studies showing th at, even in psoriasis, the dividin g cells were 
found primarily in the first 3 layers o f basa l and supra basa l k er-
at inocy tes [6-9]. How th ese findi ngs relate to the abno rm al pro-
liferatio n in psoriasis and abn o rmalities in o ther hormonal and 
enzy m atic d ifferences in pso riati c skin such as cyclic nucl eo tides 
\26\, phospho lipase A2 [271, calmodulin [28,29], o r plasma m em-
brane g lycop rotcins [30-32] is unknown . Our preliminary studies 
with o th er h yperprolifcrati ve skin diseases (lichen pl anus, verruca 
vul ga ri s, cond ylo m a acumin atum , basa l cell and squ am o us cell 
ca rcino m a) have no t produced the same distribution of EGF re-
cepto rs seen in pso riasis vul ga ris. 
Whether these [125 l)EGF binding sites and irnmunoreactive EGF 
recep tors detected in the involved psoriatic skin in the present 
stud y represent biolog ica ll y active EGF receptor with its asso-
ciated tyrosyl kinase ac tivity is also not known . Epidermal growth 
factor stimulated the phosphory lation of a 170,000 dalto n protein 
in ex tracts of no rm al hum an ep idermi s (Fig 4) , pres umptively the 
EG F recepto r w ith its intrinsic ty rosine kin ase activity. However , 
Gentlem an et a! [33] recentl y showed that tyrosyl kinase and 
phosp hotyrosy l phosphatase ac tivity were in creased 2-fold in ac-
tive les ions of pso ri as is co mpared w ith uninvo lved skin. In thei r 
studies the tyrosy l kinase activit y in these studies was not stim-
ul ated b y EGF or platelet-derived g rowth facto r (PDG F) when 
the sa mples were solubilized . Whether this increased ty rosyl ki-
nase and phosphatase acti vity was actually du e to EGF, another 
known g rowth factor such as PDGF, a viru s o r oncogene ty rosyl 
kinase was not answe red. T he am o unt of tissue required to prove 
th at the EGF recepto r kin ase activity is increased 2-fold prevented 
us fro m reso lving this ques ti on. Morpho m etric analysis of sil ver 
grains in the present study independently indicates a 2-fold. in-
crease in f 1251]EG F binding in the upper layer of psoriatic epi-
dermis so that the m ost likely source o f the in creased tyrosyl 
kinase acti vity in pso ri atic lesions is th at of the EGF receptor. 
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